Phys.org on MSN14 天
New Peptide Drug Remains Effective Against Variable SARS-CoV-2 Spikes
Researchers from the Institute of Science Tokyo have developed CeSPIACE, a peptide inhibitor that blocks SARS-CoV-2 from ...